Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01492816 · ClinicalTrials.gov registry record · NA
Enhancement of Connect to Protect® (C2P)
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 927
- Enrollment target
NCT01492816: Completed NA study, sponsored by University of North Carolina, Chapel Hill.
NCT01492816 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 927 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (34% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01492816, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 927 participants
- Enrollment target
Study Summary
The proposed study seeks to continue Connect to Protect® (C2P) community mobilization efforts that have developed coalitions that plan for and bring about structural changes for purposes of reducing HIV incidence and prevalence among youth in targeted communities at nine sites.
Primary Outcome
Assessment will include evaluation across three primary intermediate outcome areas: 1. Achievement of SCOs (programs, policies, practices) that target increased levels of HIV-related prevention, testing, and linkage to healthcare. 2. Increased community capacity and social capital to address HIV-related prevention, testing, and linkage to healthcare. 3. Increasing levels of sustainability across the HIV continuum of care (CoC) including prevention, testing, and linkage to healthcare activities
Interventions
- BEHAVIORAL Community Mobilization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 927 participants |
| Start Date | 2011-08 |
| Est. Completion | 2016-05 |
| Phase | NA |
What the finished NCT01492816 record still lists
NCT01492816 is an interventional study that assigns participants to a tested intervention. The registered 927 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (34% lower).
The record links to 0 conditions, and to 1 intervention - of which Community Mobilization is the first listed.
NCT01492816 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01492816 about?
NCT01492816 is a clinical study titled "Enhancement of Connect to Protect® (C2P)". The proposed study seeks to continue Connect to Protect® (C2P) community mobilization efforts that have developed coalitions that plan for and bring about structural changes for purposes of reducing HIV incidence and prevalence among youth in targeted communities at nine sites.
What is the current status of trial NCT01492816?
This trial is currently completed. It is a NA study. The enrollment target is 927 participants. The study started on 2011-08. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01492816?
The interventions under investigation include: Community Mobilization (BEHAVIORAL).
Who is sponsoring clinical trial NCT01492816?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01492816's enrollment target sits among peer trials
927 123rd of 2000 higher than 1,878 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06378541 · 928 participants · NA
Smartphone App Enhanced Facilitation Among Veterans in a Mental Health Inpatient Setting (Project HOPE)
- NCT06555029 · 929 participants · NA
Oral Health Intervention in Adult Primary Care
- NCT03995082 · 925 participants · NA
Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey
- NCT05216432 · 930 participants · Phase 1
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia